MaxCyte, Inc.
MXCT
$1.04
-$0.05-4.59%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 32.21% | 6.90% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 32.21% | 6.90% | |||
| Cost of Revenue | -2.55% | 0.88% | |||
| Gross Profit | 42.04% | 8.73% | |||
| SG&A Expenses | 14.07% | -17.35% | |||
| Depreciation & Amortization | -2.40% | -0.29% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 11.36% | -20.64% | |||
| Operating Income | 10.63% | 37.60% | |||
| Income Before Tax | 50.50% | 22.71% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 50.50% | 22.71% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 50.50% | 22.71% | |||
| EBIT | 10.63% | 37.60% | |||
| EBITDA | 12.29% | 41.57% | |||
| EPS Basic | 50.61% | 22.83% | |||
| Normalized Basic EPS | 10.32% | 43.53% | |||
| EPS Diluted | 50.61% | 22.83% | |||
| Normalized Diluted EPS | 10.32% | 43.53% | |||
| Average Basic Shares Outstanding | 0.13% | 0.11% | |||
| Average Diluted Shares Outstanding | 0.13% | 0.11% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||